RxDoctor Payments Data

Laura Hay

Nurse Practitioner · Reno, NVNPI 1891935268

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.4% of the total across 244 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,069in general payments, 2019–2025

Across 244 payments — averaging $33.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • Novartis$983
  • Incyte Corporation$720
  • AbbVie$659
  • Lilly USA, LLC$590
  • E.r. Squibb & Sons, L.L.C.$538
  • plus $3K from 17 others

What the payments were for

  • Food & beverage$7,85897%
  • Education$2103%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,069 in reported general payments places this provider in the 95th percentile of 933 nurse practitioner providers in Nevada.

See all nurse practitioner providers in Nevada

Medicare billing

Part B allowed, 2024
$210,184
Medicare patients
701
Services billed
5,550

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab13$57,382
Fluorouracil68$3,235
Clobetasol Propionate72$2,860
Ketoconazole110$1,841
Doxycycline Hyclate55$1,330
Metronidazole17$901
ValacyclovirValacyclovir Hcl19$616
Triamcinolone Acetonide68$501
Ammonium Lactate22$445
Clindamycin Phosphate11$217
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip15$184
Acyclovir32$113

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Reno

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →